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Edited by David LambethAbstract In the model P450 BM3 system, the P450 is fused to
its diﬂavin reductase partner in a single polypeptide. BM3 dimer-
izes in solution, but the catalytic relevance of the phenomenon
was hitherto unknown. We show that BM3 fatty acid hydroxy-
lase speciﬁc activity decreases sharply at low enzyme concentra-
tions, consistent with separation of active dimer into inactive
monomer. Reductase-dependent speciﬁc activities are maintained
or enhanced at low concentration, suggesting inter-ﬂavin electron
transfer is unaﬀected. Fatty acid oxidation is reconstituted by
mixing inactive oxygenase (A264H) and FMN-depleted
(G570D) mutants, demonstrating that inter-monomer (FMN1-
to-heme2) electron transfer supports oxygenase activity in the
BM3 dimer.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The cytochromes P450 (P450s) are a superfamily of heme-
containing mono-oxygenases that catalyse activation of molec-
ular oxygen and the oxygenation of a huge range of organic
molecules, including fatty acids, sterols/steroids and various
xenobiotics [1]. In the P450 catalytic cycle, two electrons are
delivered sequentially from redox partner(s) enabling ﬁrst the
binding and then reductive activation of dioxygen. Bound
dioxygen is cleaved to produce a water molecule, leaving a
highly reactive ferryl iron-oxygen form as the species that oxy-
genates a proximally bound substrate [2].
Two major types of redox system supporting P450 catalysis
have been extensively characterized. In the class I system (typ-
iﬁed by the Pseudomonas putida camphor hydroxylase P450
cam [CYP101]) electrons are delivered from NAD(P)H to theAbbreviations: BM3, ﬂavocytochrome P450 BM3 from Bacillus mega-
terium; CO, carbon monoxide; AUC, analytical ultracentrifugation;
eT, electron transfer; NOS, nitric oxide synthase
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or ﬂavodoxin [3]. In the class II system (typiﬁed by hepatic
drug-metabolizing P450s), a NADPH-dependent diﬂavin
reductase (cytochrome P450 reductase or CPR) interacts di-
rectly with the P450s. In eukaryotic class II systems, both
CPR and the P450s are integral membrane proteins. This has
long proved an obstacle for the detailed characterization of
these enzymes. However, atomic structures are available for
a number of mammalian P450s (and for several soluble pro-
karyotic P450s) and for rat CPR, e.g. [4–7]. However, the
structures are for enzymes modiﬁed to remove their N-termi-
nal membrane anchor, and this regions is essential for produc-
tive electron transfer (eT) interactions between CPR and P450s
[4]. For this reason, ﬂavocytochrome P450 BM3 (BM3 or
CYP102A1) from Bacillus megaterium has proven an invalu-
able model system for class II P450s. BM3 is a soluble class
II system in which a fatty acid hydroxylase P450 (N-terminus)
is fused to a CPR in a single polypeptide [8]. Electron transfer
between the two modules is highly eﬃcient, with NADPH-
dependent fatty acid hydroxylation (typically at the x-1 to
x-3 positions) occurring at 17000 turnovers min1 with ara-
chidonic acid [9]. BM3 was discovered in the early 1980s by
Fulcos group at UCLA, and several homologues have been
discovered in recent years, e.g. [10]. However, the ﬁrst enzymes
recognized with structural and mechanistic similarities to BM3
were eukaryotic nitric oxide synthases (NOS), e.g. [11]. The
eukaryotic NOSs are a group of three distinct enzyme iso-
forms in which a cytochrome domain is fused to a NADPH-
binding CPR-like module. While the heme-containing domain
is structurally distinct to the P450s, the heme iron is axially
coordinated by cysteinate and water ligands (as in P450s)
and NOS also catalyses the reductive activation of molecular
oxygen – forming nitric oxide (NO) and citrulline from argi-
nine in two successive catalytic cycles [12].
NOS enzymes were shown to be active as dimers, with inter-
protomer (FMN1-to-heme2) eT facilitating catalysis [13]. BM3
has also been shown to oligomerize in solution [14], but there
has been no previous attempt to understand the relationship
between oligomeric state and catalytic activity in this pivotal
P450. Here we present studies on catalytic properties of wild-
type and mutant forms of BM3 which demonstrate conclu-
sively that the dimeric form is the species that is catalytically
functional, and that inter-protomer eT supports fatty acid
hydroxylase activity.ation of European Biochemical Societies.
R. Neeli et al. / FEBS Letters 579 (2005) 5582–5588 55832. Materials and methods
2.1. Molecular biology
Wild-type P450 BM3 was expressed from E. coli strain TG1 using
plasmid pBM25, as described previously [15]. Construction of the
FMN-deﬁcient mutant (G570D) of BM3 has been described
previously [16]. The A264H mutant of P450 BM3 was generated
in plasmid pBM25, using the Stratagene QuikChange mutagenesis
kit with mutagenic primers A264H-F 5 0CATTCTTAATTCATGG-
ACACGAAACAACAAGTGG3 0 and A264H-R 5 0CCACTTGTTG-
TTTCGTGTCCATGAATTAAGAATG3 0. Oligonucleotide primers
for mutagenesis were synthesized in the Protein and Nucleic Acid
Chemistry Laboratory (PNACL) at Leicester (UK). Mutated bases
for generation of the H264 residue are underlined. The A264H
mutation was veriﬁed by DNA sequencing of the entire clone.
Molecular biology was done by standard methods [17].
2.2. Expression and puriﬁcation of wild-type and mutant forms of
ﬂavocytochrome P450 BM3
Wild-type and mutant forms of BM3 proteins were expressed in
TG1, typically from 5 l cultures in LB medium or Terriﬁc Broth
(TB) containing ampicillin (50 lg/ml) [9,17]. Expression was under
control of the native promoter and high levels of BM3 protein produc-
tion were achieved in stationary phase of the culture. Transformant
cells were collected and disrupted, and proteins puriﬁed by column
chromatography steps on DEAE Sephacel and 2 0,5 0 ADP agarose res-
ins, as previously [9]. At all stages, protein degradation was minimized
by maintenance of samples on ice, and by addition of protease inhib-
itors (Roche Complete protease inhibitor tablet). Proteins were >95%
pure following these steps. Enzyme puriﬁcation to homogeneity was
achieved by gel ﬁltration (Sephacryl S-200 column) [9]. Pure enzymes
were concentrated by ultraﬁltration to between 0.5 and 1 mM and dia-
lysed into buﬀer A (50 mM Tris–HCl, pH 7.2) containing 50% (v/v)
glycerol prior to storage at 80 C. P450 concentration was deter-
mined by the method of Omura and Sato [18].
2.3. Steady-state kinetic studies
All steady-state measurements were performed at 25 C in 50 mM
potassium phosphate (pH 7.0, assay buﬀer). To examine eﬀects of en-
zyme concentration on speciﬁc activity of fatty acid hydroxylation,
lauric acid oxygenation by wild-type BM3 was measured by following
NADPH oxidation at 340 nm (340 = 6210 M
1 cm1) with 0.5–
100 nM enzyme and near-saturating concentrations of both NADPH
(200 lM) and laurate (500 lM). The assay set was repeated in the pres-
ence of free FMN (250 nM) to account for any activity changes due to
FMN loss from BM3 at low enzyme concentration. For similar anal-
ysis of BM3-dependent reduction of cytochrome c and potassium fer-
ricyanide, the same enzyme concentration range was used with
NADPH (200 lM) and either cytochrome c (400 lM) or ferricyanide
(750 lM) at near-saturating concentrations. Cytochrome c reduction
was measured at 550 nm (550 = 22640 M
1 cm1) [9] and ferricyanide
reduction at 420 nm (420 = 1020 M
1 cm1). Values used were aver-
ages of at least three determinations, varying by <5%. All kinetic mea-
surements were made using a Cary UV-50 Bio UV–visible
spectrophotometer (Varian).
To compare rates of laurate-dependent NADPH oxidation catalyzed
by wild-type and G570D/A264H mutants of BM3, enzymes (50 nM of
individual forms or 25 nM each of a G570D/A264H mixture) were
mixed in assay buﬀer with lauric acid (500 lM) and NADPH
(200 lM) and DA340 (indicating NADP
+ formation) followed over per-
iod of up to 5 min. To determine eﬀects of pre-incubation of an
equimolar mixture of the G570D/A264H mutants on initial rate of lau-
rate-dependent NADPH oxidation, enzymes (both at a concentration
of 10 lM) were mixed in assay buﬀer at 25 C for periods of up to
1 h, prior to dilution into the assay mixture. The assay mixture con-
tained G570D/A264H enzymes (both at 25 nM), laurate (500 lM)
and NADPH (200 lM). NADPH oxidation was then monitored at
340 nm over periods of up to 5 min as above. Assays for laurate-depen-
dent NADPH oxidation were also performed following pre-incubation
of wild-type BM3 and equimolar mixtures of the G570D/A264H mu-
tant forms with dithiothreitol (DTT). Enzyme samples (5 lM for wild-
type, 2.5 lM each for the mutant enzymes) were incubated with DTT
(2 or 10 mM ﬁnal concentration) for periods up to 1 h, prior to dilu-
tion of samples into the assay mix (ﬁnal enzyme concentration50 nM) and initiation of the assay by addition of NADPH (500 lM)
and laurate (500 lM). NADPH oxidation was monitored by DA340,
as described above. All measurements were made at least three times
at each substrate concentration. Values reported were the averages
of at least three determinations, varying by less than 5%.
2.4. Stopped-ﬂow kinetic studies
To determine the rate of ﬂavin (FMN)-to-heme eT in BM3 and mu-
tant forms thereof, formation of the dead-end carbon monoxy complex
of the heme iron was followed at 450 nm by stopped-ﬂow methods.
Experiments were performed at 25 C in assay buﬀer using an Applied
Photophysics SF.18 MV stopped-ﬂow spectrophotometer, as described
previously [9]. Enzyme (2 lM) in the ﬁrst syringe was mixed with
NADPH (400 lM) and laurate (1 mM) in the second syringe. In ad-
vance of preparation of solutions used, buﬀer was deoxygenated by
bubbling with oxygen-free nitrogen, and then saturated with carbon
monoxide (CO) by bubbling with the gas. Absorption change at
450 nm (reﬂecting formation of the ferrous-CO adduct) was monitored
following stopped-ﬂow mixing, and transients ﬁtted to a single expo-
nential process using Applied Photophysics software, as previously
[9]. Stopped-ﬂow experiments were performed for wild-type BM3,
for A264H and G570D mutants in isolation, and for mutants pre-
mixed and incubated for time periods up to 1 h.
2.5. Analysis of products of wild-type and mutant P450 BM3-dependent
hydroxylation of lauric acid
Capacity of wild-type and mutant forms (A264H, G570D and mix-
tures of the mutants) to hydroxylate the lipid substrate lauric acid was
established using LCMS methods. Reactions were performed by incu-
bation of enzyme (1 lM) with lauric acid (1 mM) and NADPH
(500 lM) in a reaction volume of 10 ml in assay buﬀer at 25 C for
10 h. Following incubation, samples were acidiﬁed to pH 2.0 with
1 M HCl and lipids extracted into one volume of dichloromethane.
The solvent/lipid sample was then mixed with solid magnesium sul-
phate to remove traces of water. The sample was then ﬁltered to re-
move MgSO4 and dried, then re-dissolved in 0.5 ml methanol. Lipid
samples were analysed by mass spectrometry following resolution of
substrate from product(s) using HPLC. Samples were resolved on an
Agilent 1100 series HPLC-MSD using an Ace 5 AQ column
(4.6 · 250 mm; Advanced Chromatography Technologies) maintained
at 30 C and with a ﬂow rate of 1 ml min1. The mobile phase con-
sisted of 0.2% acetic acid in water (solvent A) and methanol (solvent
B). Initial conditions were set at 38% A, 62% B. This was held isocrat-
ically for 18 min before solvent B was increased to 100%. The ion trap
mass spectrometer was operated in the negative electrospray mode.
2.6. Materials
Restriction enzymes and DNA ligase were purchased from New
England Biolabs or Stratagene. Quikchange mutagenesis kit was from
Stratagene. All other reagents were from Sigma Aldrich (Poole, UK)
and were of the highest grade available.3. Results and discussion
3.1. Speciﬁc activity of wild-type P450 BM3 as a function of
enzyme concentration
Previous studies of wild-type P450 BM3 (using gel ﬁltration
and analytical ultracentrifugation (AUC)) indicated the en-
zyme was predominantly dimeric in solution [14]. However,
the inﬂuence of oligomerization on activity of BM3 is un-
known. BM3 catalyses NADPH-dependent hydroxylation of
a range of fatty acids at rates considerably higher than all
other P450 mono-oxygenases [19]. To determine inﬂuence of
BM3 concentration on speciﬁc activity of the enzyme, we mea-
sured the speciﬁc rate of fatty acid-dependent NADPH oxida-
tion (using laurate as substrate) as a function of BM3
concentration. The initial rate of NADPH oxidation was rela-
tively constant at enzyme concentrations at or above 10 nM
(50 ± 2 s1), but decreased sharply at lower concentrations,
5584 R. Neeli et al. / FEBS Letters 579 (2005) 5582–5588to as low as 10.4 s1 at the lowest enzyme concentration
(0.5 nM). A plot of speciﬁc rate of NADPH oxidation versus
BM3 concentration was hyberbolic and data ﬁtting gave a
limiting rate of BM3-dependent NADPH oxidation of
53.2 ± 1.3 s1 and a value of 1.1 ± 0.2 nM as the apparent
BM3 concentration at which speciﬁc activity was half maxi-
mal. An obvious explanation for the phenomenon is that the
BM3 dimer is the species active in fatty acid hydroxylation,
and that the value of 1.1 ± 0.2 nM reﬂects the Kd for the
dimerization of BM3 monomers (Fig. 1A).
BM3 binds three cofactors are essential for eT and cataly-
sis. The P450 domain contains heme that is tightly (but non-
covalently) bound [20]. The fused reductase domain contains
FAD and FMN cofactors. FAD is also tightly bound, partly
due to extensive contacts between apoprotein and the adenine
nucleotide portion of the cofactor. However, FMN is bound
more weakly and is readily dissociated by mild treatment with
chaotropes [21]. Fulcos group recognized that FMN is bound
more weakly to BM3 than the FAD cofactor, and character-0 10 20 30 40 50
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Fig. 1. Enzyme concentration dependence of P450 BM3 speciﬁc activity.
(A) The graph shows apparent speciﬁc activity for BM3-catalysed
laurate-dependent NADPH oxidation across a BM3 concentration
range between 0 and 50 nM. Speciﬁc activity decreases dramatically at
enzyme concentrations less than 10 nM. Data points shown are the
averages of at least three measurements, each deviating by <5%. Data
are ﬁtted to a rectangular hyperbola, producing an apparent Kd value
of 1.1 ± 0.2 nM. (B) Dependence of ferricyanide reductase speciﬁc rate
on BM3 concentration.ized both G570 and W574 as residues important for FMN
binding [16]. The G570D mutant was shown to have negligible
FMN content and to be non-functional as a fatty acid hydrox-
ylase, even in the presence of exogenous FMN up to 1 mM
[16]. To establish whether FMN loss from wild-type BM3
might explain decreases in speciﬁc activity at low enzyme con-
centration, we repeated the above experiments with FMN
(250 nM) in the assay buﬀer. An essentially identical data set
was obtained (limiting speciﬁc rate = 52.8 ± 3.2 s1 and appar-
ent Kd = 0.8 ± 0.2 nM), indicating that FMN dissociation does
not underlie the decrease in speciﬁc activity at low BM3
concentrations.3.2. Reduction of exogenous electron acceptors
Aside from its fatty acid hydroxylase activity, BM3 also
catalyses reduction of various electron acceptors [9]. Cyto-
chrome c is a paradigm substrate for the CPR family, with
eT occurring from the FMN cofactor. By contrast, ferricya-
nide is reduced predominantly via eT from the FAD cofactor.
Speciﬁc cytochrome c and (potassium) ferricyanide reductase
activities of BM3 were also measured as a function of BM3
concentration as described in Section 2. The results obtained
were distinctly diﬀerent from those for fatty acid turnover.
For cytochrome c reduction, speciﬁc activity for wild-type
BM3 remained constant (70 ± 5 s1) across the enzyme con-
centration range between 2 and 50 nM. A small decrease in
speciﬁc activity of cytochrome c reduction was noted at lower
enzyme concentrations, but only to 57 s1 at 0.5 nM enzyme.
Since eT to both the covalently attached heme domain and
to the separate cytochrome c molecule occurs via the FMN ﬂa-
vin in BM3 reductase, the results indicate that FMN-to-heme
eT is diﬀerentially aﬀected in the two systems. Assuming that
dissociation of the BM3 dimer at low enzyme concentration
results in loss of fatty acid hydroxylase activity, then mono-
merization does not substantially diminish eT to cytochrome
c. This suggests that eﬃcient eT occurs between FAD and
FMN cofactors within the BM3 monomer enabling rapid eT
to cytochrome c from the monomeric form, but that the
FMN of a BM3 monomer is not a competent electron donor
(for one or both of the electrons required) to its own heme
to allow fatty acid oxygenation.
Preceding stopped-ﬂow studies of NADPH-dependent FAD
reduction in theBM3FADdomain showed that the limiting rate
of eT (klim) is 364 ± 25 s
1 at 5 C [22], substantially faster than
in relatedmembers of the diﬂavin reductase family, e.g., eukary-
otic CPR andNOS). As expected, eT fromBM3FAD to ferricy-
anide is rapid (speciﬁc activity is 191 s1 at 50 nMBM3) and the
apparent eT rate is relatively constant across the enzyme range
from 20 to 50 nM. However, a progressive increase in speciﬁc
ferricyanide reduction rate was observed at lower enzyme con-
centrations. At 5 nM BM3 the rate was 280 s1, and at 2 nM
the rate rose to 357 s1 (Fig. 1B). The apparent acceleration of
eT to ferricyanide may indicate that access to the FAD ﬂavin
is partially occluded in the dimer, but that productive interac-
tions with the FAD are improved in the monomeric form of
the enzyme. To investigate further, kcat and KM parameters for
ferricyanide reduction were determined at three diﬀerent BM3
concentrations (0.45, 9 and 45 nM). Both the kcat and KM
parameters for ferricyanide reduction changed as BM3 concen-
tration was varied: kcat = 1790 ± 40 s
1, KM = 22.7 ± 2.2 lM
(0.45 nM BM3); kcat = 554 ± 28 s
1, KM = 68.6 ± 10.0 lM
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1, KM = 114 ± 69 lM (45 nM
BM3). These data are consistent with the accelerated rates of
eT to ferricyanide at low BM3 concentration, and suggest that
the BM3 monomer has higher aﬃnity for ferricyanide (likely
through easier access to the FAD site, which may be slightly oc-
cluded in the dimer) and is able to reduce this electron acceptor
faster than can the dimer. At low BM3 concentrations,
NADPH-dependent reduction of FAD likely becomes rate-lim-
iting for ferricyanide reduction by the monomeric form of BM3.
3.3. Establishing inter-monomer electron transfer through use of
mutant forms of P450 BM3
With reference to previous studies of NOS [13], we consid-
ered that not only might the dimeric form of BM3 be obliga-
tory for fatty acid hydroxylation, but in addition that eT
should occur between the reductase domain of one subunit
and the heme domain of the other to support fatty acid
hydroxylation. We tested this hypothesis by analysing the ki-
netic properties and, more speciﬁcally, laurate hydroxylase
activity of two mutant forms of BM3 in which either (i)
FMN binding is eﬀectively abolished (G570D), or (ii) in which
the heme domain is non-functional. For the heme-defective
mutant, we created the A264H variant. Previously, we have
characterized an A264E mutant in which the introduced gluta-
mate residue coordinates the heme iron in the distal position.
While A264E inhibits signiﬁcantly fatty acid hydroxylation,
the mutant retains 25% of the wild-type activity, due to dis-
placement of E264 from the iron during the catalytic cycle [23].
In contrast, our studies of the A264H variant indicate that the
imidazole sidechain of H264 is completely coordinated to the
heme iron in both substrate-free and substrate (arachidonate)
bound forms of A264H BM3 and its heme domain (Fig. 2).
To determine whether eT between monomers of the BM3 di-300 400 500 600 700
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Fig. 2. Optical properties of wild-type and A264H mutant BM3 heme
domains. UV–visible spectra are shown for wild-type BM3 heme
domain in substrate-free form (thick solid line, 6 lM) and arachidonic
acid-bound (300 lM, thin solid line) forms. In the substrate-free form
the heme Soret maximum is at 418 nm. On near-saturation with
substrate the Soret shifts to 394 nm. For the A264H heme domain
without substrate (6 lM, dashed line) the Soret band is located at
427 nm. There is no signiﬁcant change in absorption induced by
addition of arachidonate (or other fatty acids) to A264H, consistent
with full occupation of the A264H heme iron distal position by the
H264 imidazole sidechain in both presence and absence of substrate.mer was essential for fatty acid oxidation, we examined inter-
actions of these two mutant ﬂavocytochromes.
Steady-state studies of fatty acid (laurate)-dependent
NADPH oxidation were performed for both the G570D
and A264H mutants in isolation, and for wild-type enzyme.
Limiting rates of fatty acid-dependent NADPH oxidation in
the mutants were substantially <1% of that for wild-type
BM3 under the same conditions (50 nM enzyme, Table 1).
When G570D and A264H were mixed in stoichiometric
amounts (25 nM ﬁnal concentration each) and assayed
immediately, there was a signiﬁcant increase in turnover
rate. On incubation of the mutants together at 25 C for
periods of up to 1 h (prior to initiating the assay by addition
of NADPH and laurate) a further >5-fold increase in
speciﬁc rate was observed (from 0.6 to 3.2 s1). No such in-
crease was observed if the individual mutants were pre-
incubated over this time period.
While the rate ofNADPHoxidationobserved following 1 hof
pre-incubation of the A264H/G570D enzymes (3.2 s1) was
much greater than that for the isolated enzymes at the same con-
centration (0.1 and 0.3 s1 forA264HandG570D, respectively),
the rate was substantially less than forwild-type BM3 (50.0 s1).
Assuming that increased rates observedwith themutantmixture
reﬂects formation of catalytically functional heterodimers
(A264H/G570D) fromnon-functional, cofactor depleted/inacti-
vated homodimers (A264H/A264H andG570D/G570D), then a
more substantial increase in activity might have been expected.
From the data for loss of wild-type fatty acid hydroxylase activ-
ity at low enzyme concentration, an apparentKd of1 nMmay
be inferred for the dimer.Thus, slowdissociation ofhomodimers
and reassociation to form heterodimers may take place. How-
ever, in recent work we have resolved the atomic structure of
the FAD/NADPH domain of BM3 (Joyce et al. [25]). Crystalli-
zation was only achieved using a C773A mutant form, which
may reduce sample heterogeneity, putatively by preventing in-
ter-molecular disulﬁde bridge(s) between FAD domains.
Possibly, BM3 homodimers may be linked (in at least aTable 1
Speciﬁc activity of laurate-dependent NADPH oxidation for wild-type
and the stoichiometric mixture of A264H/G570D mutants of P450
BM3
P450 BM3
enzyme(s)
Incubation
time (min)
Speciﬁc activity (s1)
No DTT 2 mM
DTT
10 mM
DTT
Wild-type 0 50.0 – –
A264H 0 0.3 – –
G570D 0 0.1 – –
A264H/G570D 0 0.6 0.9 1.1
10 1.5 1.7 2.9
20 1.8 3.6 3.3
30 2.3 4.4 4.4
45 3.0 4.5 4.9
60 3.2 5.4 5.2
O/N – 9.7 11.5
Assays were performed as described in Section 2, with A264H and
G570D mutants at ﬁnal concentrations of 25 nM each in the assay, and
with enzymes pre-incubated in absence of DTT, or in presence of 2 or
10 mM DTT. Pre-incubation of wild-type BM3 and the isolated
A264H and G570D mutants with DTT did not result in any signiﬁcant
rate enhancement.
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Fig. 3. Steady-state kinetic evaluation of laurate oxidation by the
A264H/G570D enzyme mixture. The A264H and G570D mutants of
BM3 were mixed (25 nM each) and assayed for laurate-dependent
NADPH oxidase activity, as described in 2. Rate versus laurate
concentration data are plotted and ﬁtted to the Michaelis–Menten
equation, producing parameters of apparent kcat = 6.5 ± 0.3 s
1 and
KM = 459 ± 39 lM.
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change between dimers. To examine this possibility, enzymes
were incubated with the reductant dithiothreitol (DTT) prior
to assays as ameans of reducing disulﬁde bridges. In preliminary
experiments it was established that high levels of DTT
(50 mM) had inhibitory eﬀect on laurate oxidation rate by
wild-type BM3, but that incubation with DTT concentrations
up to10 mMhad negligible eﬀect on the turnover rate. To dis-
cover whether incubation of A264H/G570D mutant mixtures
with DTT caused further increases in activity, mutants were
mixed as before and pre-incubated with DTT (2 or 10 mM) for
periods up to 1 h prior to assay initiation by substrate addition.
The results (Table 1) demonstrate clearly that A264H/G570D
incubation with DTT results in recovery of substantially more
activity than in the absence of DTT. Following 1 h incubation
with 2 mM DTT, laurate-dependent NADPH oxidase activity
of the mixture is 5.4 s1 (cf. 3.2 s1 without DTT). For incuba-
tion with 10 mMDTT, rate enhancement is similar over the per-
iod of one hours pre-incubation. For the untreated enzyme
mixture there is negligible further improvement in activity fol-
lowing further pre-incubation. However, further enhancements
of activity are observed for themutants pre-incubated overnight
(14 h) with either 2 or 10 mM DTT, reaching levels that are
3-fold and 3.5-fold greater, respectively, than for untreated
enzymes. Negligible activity changes were observed for isolated
A264H and G570D mutants pre-incubated with DTT. These
data are consistent with the DTT-dependent reduction of disul-
ﬁde bridge(s) in the homodimeric mutants, enabling enhanced
formation of catalytically active heterodimers. Since G570D
binds no FMN and A264H has a hexacoordinated heme iron
(preventing access of oxygen to the iron), these data are consis-
tent with requirement for inter-monomer eT in the A264H/
G570D heterodimer. This eT almost certainly occurs between
the FMN in A264H and the heme in G570D. Assuming this
model (as for NOS, 13) is correct, speciﬁc rate of NADPH oxi-
dation by the A264H/G570D heterodimer could not be >50%
of that for the wild-type homodimer. This is since eT between
G570D reductase and A264H heme is unlikely due to absence
of FMN in the former and inactivation of the heme in the latter.
To examine steady-state kinetic parameters for laurate turn-
over, the A264/G570D (25 nM ﬁnal concentration of both) mu-
tants were mixed and incubated for 1 min prior to initiation of
assays at various laurate concentrations (0–900 lM), and with
NADPH maintained near-saturating at 200 lM. The plot of
speciﬁc rate versus fatty acid hydroxylation was hyperbolic, ﬁt-
ting accurately to the Michaelis–Menten function and produc-
ing parameters of apparent kcat = 6.5 ± 0.3 s
1 and apparent
KM = 459 ± 39 lM(Fig. 3). The kcat value is5-fold lower than
for the wild-type enzyme under similar conditions and the KM
2-fold greater (perhaps reﬂecting in some part that only one
of the twoheme sites in theA264H/G570Dheterodimer is active,
while bothmay bind laurate). However, it is clear that a substan-
tial amount of fatty acid-dependent NADPH oxidase activity is
recovered by mixing of the two non-functional mutants.
3.4. Stopped-ﬂow analysis of ﬂavin-to-heme electron transfer
To investigate the restoration of eT between reductase FMN
of A264H and the heme of G570D, stopped-ﬂow studies of eT
from FMN-to-heme were performed for wild-type BM3, for
the individual A264H and G570D mutants and for the
A264H/G570D mixture in CO-saturated buﬀers containing
laurate and NADPH, as previously [9]. If FMN-to-heme eToccurs, complexation of CO with the ferrous heme produces
the stable Fe2+–CO (P450) complex with absorption maximum
at 450 nm. By following absorption development at 450 nm
in the stopped-ﬂow, an estimate of the FMN-to-heme electron
transfer rate is obtained. For wild-type P450 BM3, a FMN-to-
heme electron transfer rate of 111 s1 was obtained. For the
G570D mutant in isolation, there was eﬀectively no electron
transfer to its own heme iron, owing to the absence of the
mediator FMN ﬂavin. For the A264H mutant in isolation, a
very small amount of Fe2+–CO complex was formed at an
apparent rate of 7 s1. However, the amplitude of the
absorption change obtained was <2% of that for the wild-type
enzyme, indicating that only a very small proportion of the dis-
tal H264 ligand can be displaced by CO. However, for the
G570D/A264H mixture, there was an immediate increase in
rate of Fe2+–CO complex formation in enzyme samples that
were not pre-incubated together (37 s1), and further rate in-
creases following pre-incubation of A264H/G570D prior to
stopped-ﬂow mixing (up to 72 ± 4 s1) following enzyme pre-
incubation for periods between 20 and 60 min. The amplitude
of absorption change on the stopped-ﬂow timescale also
increased from 10% of that observed for wild-type BM3
immediately on mixing to >20% of the amplitude following
20 min or more pre-incubation of A264H/G570D samples.
These data are thus consistent with eT between FMN of the
A264H enzyme and heme of the G570D enzyme in a heterodi-
mer. To establish whether observed increases in steady-state
laurate-dependent NADPH oxidation and accelerated FMN-
to-heme eT in the A264H/G570D BM3 mixture were also
associated with fatty acid hydroxylation, we undertook
analysis of lipid products from turnover assays.
3.5. Lauric acid hydroxylation by wild-type and A264H/G570D
enzymes
NADPH-dependent turnover of the P450 BM3 fatty acid sub-
strate lauric acid was undertaken by HPLC-MS, as described in
Section 2. Reactions were set up containing wild-type BM3, the
R. Neeli et al. / FEBS Letters 579 (2005) 5582–5588 5587isolatedA264HandG570Dmutants, and the equimolarmixture
of A264H/G570D. Preceding HPLC-MS studies of lauric acid
alone showed a prominent peak for laurate eluting at
23.5 min. The m/z ratio for the compound was 199.0, consis-
tentwith that for the singly charged, deprotonated formof lauric
acid. On incubation of wild-type BM3 with laurate, there was
substantial conversion to a species with HPLC retention time
of 12.8 min. The shorter retention time was consistent with a
more polar product (i.e., an oxygenated form) and the product
had a m/z value of 214.9, consistent with mono-oxygenation.
Previous studies have demonstrated that wild-type BM3
produces almost exclusively 11-hydroxylaurate from laurate
[24]. Using either G570D (as shown earlier, 16) or A264H in iso-
lation, there was no conversion of laurate to any product. Thus,
the very small amount of ﬂavin-to-heme eT measured by
stopped-ﬂow for A264H did not facilitate any detectable fatty
acid oxygenation.However, whenA264H/G570Dmutants were
mixed prior to assay, substantial amounts of a product of the
same HPLC retention time and m/z ratio were observed as for
wild-type BM3. ESI tandem MS analysis of the hydroxylated
product by collision-induced disassociation is depicted in
Fig. 4. The fragmentation pattern observed conﬁrms that the
reaction is mono-disperse, with the product being identiﬁed as
11-hydroxylauric acid (for both wild-type and the mutant
mixture). The spectrum exhibits a number of non-characteristic
signals at m/z 197 (A-18, loss of H2O), m/z 179 (A
-36, loss of
twoH2Omolecules),m/z 171 (A
-44, loss of CO2 or CH3CHO),
m/z 169, m/z 155, m/z 153 (A-62, loss of H2O and CO2), and a
relatively weak characteristic signal at m/z 127 (A-88) which
is probably due to the combined loss of CO2 and CH3CHO.
Thus, compelling evidence is presented that inter-monomer
(FMN-to-heme) eT occurs in the dimeric BM3 enzyme, and that12812011210496888072
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Fig. 4. ESI tandem mass spectrum of the carboxylate anion (MS2 215) of 1
shown derives from oxygenation of lauric acid by the A264H/G570D enzymthis mode of electron transport is essential for eﬃcient mono-
oxygenation of lauric acid.4. Conclusions
Preceding hydrodynamic studies of BM3 showed it to be
predominantly dimeric [14]. Here we demonstrate
conclusively that fatty acid-dependent activity of BM3 is
dramatically reduced at low enzyme concentration, consis-
tent with separation of the dimeric form into an inactive
monomer (with Kd of 1 nM). Reduction of cytochrome c
is marginally aﬀected at low enzyme concentration.
However, ferricyanide reduction rate increases at low
enzyme concentration, consistent with improved interactions
between the electron acceptor and the BM3 monomer.
Through use of two non-functional fatty acid hydroxylase
mutants (the hexa-coordinated heme iron A264H variant
and the FMN-depleted G570D mutant) we have shown that
substantial enhancement of ﬂavin-to-heme eT rate occurs
when the two mutants were mixed together. HPLC-MS
studies of lauric acid oxidation proved conclusively that
both wild-type BM3 and the A264H/G570D mixture were
functional as laurate (x-1) hydroxylases, while the individual
mutants had no measurable fatty acid hydroxylase activity.
These data indicate that inter-subunit eT (FMN1 to heme2)
is required for fatty acid hydroxylation in the BM3 dimer.
These ﬁnding demonstrate conclusively that the dimeric
form of BM3 is catalytically functional as a fatty acid
hydroxylase, while eT from the reductase domain to
exogenous electron acceptors can occur in the monomer.200192184176168160152144136
154.9
168.8
170.8
178.9
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1-hydroxy laurate with inset showing characteristic fragments. Product
e mixture.
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